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We previously used a human artificial chromosome (HAC) with a synthetic kinetochore that could be targeted with
chromatin modifiers fused to tetracycline repressor to show that targeting of the transcriptional repressor tTS within
kinetochore chromatin disrupts kinetochore structure and function. Here we show that the transcriptional corepressor
KAP1, a downstream effector of the tTS, can also inactivate the kinetochore. The disruption of kinetochore structure by
KAP1 subdomains does not simply result from loss of centromeric CENP-A nucleosomes. Instead it reflects a hierarchical
disruption of the outer kinetochore, with CENP-C levels falling before CENP-A levels and, in certain instances, CENP-H
being lost more readily than CENP-C. These results suggest that this novel approach to kinetochore dissection may reveal
new patterns of protein interactions within the kinetochore.
INTRODUCTION
The centromere/kinetochore is one of the most complex
cellular substructures, with more than 80 protein compo-
nents described to date (reviewed in Carroll and Straight,
2006; Cheeseman and Desai, 2008; Fukagawa, 2008; Vagnarelli
et al., 2008). These components perform the complex job of
attaching chromosomes to the mitotic spindle; ensuring that
those attachments are correct; signaling to delay mitotic
progression if they are not, and regulating the movements of
the chromosomes toward the spindle poles in anaphase.
The kinetochore is assembled at a unique locus on each
natural chromosome. However, for organisms with regional
centromeres (Pluta et al., 1995), this reflects only a prefer-
ence¤, and not an absolute requirement for particular DNA
sequences. Kinetochores can form on a wide range of single-
copy and repeated DNA sequences, leading to the conclu-
sion that the ultimate determinants of kinetochore assembly
are epigenetic. The long-term purpose of our studies is to
determine the epigenetic “landscape” that promotes kineto-
chore assembly and its maintenance during cell divisions.
Experiments including yeast genetics, RNA interference
(RNAi) studies in mammalian cells, and gene knockout anal-
ysis in mouse and chicken DT40 cells have revealed that
kinetochores assemble on a foundation of specialized chro-
matin containing the kinetochore-specific histone H3 variant
CENP-A (Earnshaw and Rothfield, 1985). CENP-A is up-
stream of almost all other known components in the kinet-
ochore assembly pathway. However, that pathway is mul-
tiplex, as recent studies in chicken and Drosophila show that
inner kinetochore proteins CENP-H and -C are required for
normal CENP-A loading or retention (Okada et al., 2006;
Goshima et al., 2007; Erhardt et al., 2008).
Our work was inspired by an approach first developed a
number of years ago in which cloned fragments of human
centromeric DNA were used to form human artificial chro-
mosomes (HACs) in HT1080 fibrosarcoma cells (Harrington
et al., 1997; Ikeno et al., 1998). Originally, HAC formation
was only achieved with regular repeated arrays of -satellite
DNA containing CENP-B boxes (Masumoto et al., 1998;
Ohzeki et al., 2002; Okada et al., 2007). We extended those
studies by developing HACs based on a synthetic alphoid-
tetO DNA array that resembles centromeric repeats, but con-
tains a tetracycline operator in every second alphoid mono-
mer (Nakano et al., 2008). This allows the targeting of a wide
range of proteins into the functional kinetochore as fusions
to tetracycline repressor. The power of this system is that it
allows the specific manipulation of the protein complement
of a single kinetochore in vivo, while leaving all other kinet-
ochores unperturbed.
We previously showed that targeting of either a transcrip-
tional activator or repressor (the tTA and tTS, respectively)
could inactivate the synthetic kinetochore (Nakano et al.,
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2008). Surprisingly, targeting of factors promoting the for-
mation of heterochromatin associated with HP1 strongly
disrupted the conditional kinetochore, as judged by loss of
centromeric proteins, alteration of the pattern of chromatin
modifications within the centromere, and destabilisation of
the HAC (Nakano et al., 2008).
The alphoidtetO HAC system has important differences
from the only other conditional centromere system, which
was developed for the point centromere of budding yeast
(Hill and Bloom, 1987). That centromere is inactivated by
being bombarded by transcription from an adjacent strong
promoter. Thus, it is not suited for the analysis of the effects
of transcriptional repressors on centromere function, a key
question, given the demonstrated role of transcription in
centromere function in Schizosaccharomyces pombe (Volpe et
al., 2002, 2003; Chen et al., 2008). Furthermore, in its inactive
state, the budding yeast conditional centromere was re-
ported to be fully occupied with CENP-A/Cse4 (Collins et
al., 2005), although this was disputed (Mythreye and Bloom,
2003). In the case of the human conditional centromere,
inactivation induced by the tTS transcriptional repressor is
accompanied by loss of CENP-A (Nakano et al., 2008).
Here, we have used the alphoidtetO HAC system to further
investigate the process of HAC disruption by the transcrip-
tional corepressor KAP1, a downstream effector of the tTS.
We show that KAP1 inactivates the HAC in a complex
manner that appears to involve a hierarchy of loss of inner
and outer kinetochore components that precedes loss of
CENP-A from centromeric nucleosomes.
MATERIALS AND METHODS
Construction of a HeLa-HT1080 Cell Line Containing an
AlphoidtetO HAC
A HT1080 cell line carrying 1 copy/cell of a HAC obtained from a synthetic
centromeric -satellite DNA incorporating a tetO sequence every second
alphoid monomer (AB2.2.18.21; Nakano et al., 2008) was fused to a HeLa cell
line resistant to the drug neomycin. AB2.2.18.21 cells, resistant to blasticidin
(the resistance marker present on the HAC DNA), were plated with neomy-
cin-resistant HeLa cells in a 50%-to-50% ratio and left to grow overnight. The
next day, growth medium was washed, and cells were incubated for 3 min
with a solution of 50% polyethyleneglycol (PEG; Roche, Indianapolis, IN) in
1 PBS. PEG was then removed by washing with warm medium, and cells
were grown in the presence of blasticidin (8 g/ml) for HAC selection and
geneticin (800 ng/ml) for HeLa selection. Several hybrid clones were obtained
from single cells and analyzed by fluorescence in situ hybridization (FISH)
with a BAC-probe (the HAC vector backbone). 1C7 cells selected for further
study were cultured in RPMI medium (Invitrogen, Carlsbad, CA) supple-
mented with 10% of fetal bovine serum (Invitrogen) and with 500 g/ml
geneticin and 8 g/ml blasticidin.
Construction of TetR:EYFP-tagged Targeting Constructs
KAP1 constructs were inserted at the C-terminus of TetR:EYFP in the plasmid
pEYFP-C1 (Nakano et al., 2008). KAP1 deletion mutants were amplified by PCR
using the following oligonucleotides as primers: 5- TTCGGCCGCAGCCTCG-
GCCT-3 (RBCC_1_Fwd), 5- GAGGGGCCATGGGTGCAGGG-3 (RBCC_1_Rev),
5- ATGGCCCCTCCAAGAGCCCC-3 (HPBD_1_Fwd), 5- CCCTCCGCAA-
GAGCCATAAGC-3 (HPBD_1_Rev), 5- GGTGGCCCGGGAACCCTGGA-3
(PHD_1_Fwd), 5- GGGGCCATCACCAGGGCCAC-3 (PHD_1_Rev). PCR
products were cloned in pGEMTeasy, cut and cloned blunt into the BglII site of
pEYFP-C1 (TetR:EYFP). TetR:EYFP:KAP1[20–559] was obtained by inserting a
stop codon at residue 559 by site-directed mutagenesis of KAP120.
Generation of the 1C7-KAP1 Cell Line and Washout
Experiments
For constructs allowing stable, puromycin-dependent expression in 1C7 cells,
the BsaHI/BspEI fragment of TetR:EYFP containing the coding sequence for
tet repressor–NLS–EYFP was ligated into the ClaI/BspEI-digested pIRES-
puro2 (Clontech, Palo Alto, CA) generating tYIP. The 2.5-kb BspEI/BclI
fragment of TetR:EYFP:KAP1 was cloned into the BspEI/BamHI-digested
tYIP backbone, generating tYIP-KAP1.
Stable transfections were carried out in the presence of 1 g/ml doxcycline,
using Fugene HD (Roche) in a transfection mix of 15 l Fugene HD reagent
and 5 g plasmid in 250 l OptiMEM (Invitrogen), essentially according to
the manufacturer’s instructions. Twenty-four hours after transfection, puro-
mycin and blasticidin were added to final concentrations of 2 g/ml and 4
g/ml, respectively. From this point onward, doxycycline was added fresh
every 2 d. Clonal lines of drug resistant 1C7 cells were isolated by limiting
dilution, and a clone showing medium-to-high levels of the fluorescent con-
struct, as determined by fluorescence microscopy, was selected for experi-
ments.
The doxycycline washout time course was started with a subconfluent
culture of 1C7-KAP1 cells growing in the presence of all drugs. The cell layer
was rinsed twice with excess D-PBS, followed by incubation in cRPMI with-
out drugs for 30 min at 37°C. This procedure was repeated once, and cells
were subsequently incubated over night in cRPMI with 2 g/ml puromycin.
The following morning, the cell layer was washed in excess D-PBS followed
by PBS/EDTA, cells were harvested in TrypLE Express (Invitrogen) and
centrifuged at 1000 rpm for 3 min. The cell pellet was resuspended in cRPMI
with 2 g/ml Puromycin and seeded on coverslips for fixation and antibody
staining as described at the relevant time points.
Immunostaining and Cytological Analysis
Immunostaining and cytological analyses were performed as described in
(Nakano et al., 2008) except that anti-CENP-A was as described in (Valdivia et
al., 1998). A DeltaVision (Applied Precision, Issaquah, WA) system based on
an Olympus IX-70 microscope stand (Melville, NY) coupled to a CH350 CCD
camera (Photometrics, Tucson, AZ) and controlled through SoftWorx (Ap-
plied Precision) was used for image acquisition of transient transfection
experiments. Images were taken using an Olympus S-Plan apocromat 100
1.40 NA oil immersion objective. Imaging of the stable 1C7-KAP1 cells was
performed on an Olympus IX-71 microscope stand coupled to a Photometrics
Cool Snap HQ camera, using an Olympus UPlanSApo 100 1.40 NA oil
immersion objective. All images were deconvolved with SoftWorx before
processing. Subsequently, SoftWorx or Image ProPlus (Media Cybernetics,
Silver Spring, MD) was used for image analysis.
For fluorescence quantification of transient transfection experiments, cells
expressing similar amounts of exogenous protein (judged by the similar
fluorescence background) were chosen and line-profile measurements were
taken on sum projections of deconvolved images. For quantification of ACA
staining at HAC and endogenous centromeres, a selected region of interest
(ROI) was defined on image projections as above. The line-profile algorithm
was also used to measure interkinetochore distances on mitotic HACs.
Fluorescence quantification of stable 1C7-KAP1 cells showing a single EYFP
spot was performed on deconvolved images with a z section spacing of 0.2
m (or 0.3 m for mitotic cells). Quantification was performed in Image Pro,
applying a custom-written macro (details available upon request). In brief,
HAC enhanced yellow flourescent protein (EYFP)-associated fluorescent spot
signals of the Texas Red–conjugated secondary antibodies within a nine-pixel
diameter, circular ROI were measured in the relevant sections. For each
section, the background over a nuclear area not showing any CENP staining
in an identical ROI was subtracted and the net values were summed. These
sum values were used to calculate the average fluorescent intensity per
section quantified (arbitrary fluorescent units per unit area).
Chromatin immunoprecipitation and Real-Time PCR
For the HAC loss assay, 1C7 cells transfected with plasmids expressing the
indicated targeting constructs were collected and genomic DNA prepared
using the DNeasy Blood and Tissue Kit (Qiagen, Chatsworth, CA) according
to the manufacturer’s instructions, including a treatment with RNase A.
Quantitative real-time PCR using a SYBR green mastermix (JumpStart, Sigma,
St. Louis, MO) was subsequently preformed using the following oligonucle-
otides: 5SDNA-F1/-R1 for 5S ribosomal DNA, tet-1/tet-3 for the alphoidtetO
array, and bsr-F/-R for the bsr marker gene (Nakano et al., 2008). For each
sample, the average ratio of the amounts of [alphoidtetO] and [bsr] to [5S
rDNA] was calculated. To determine the relative HAC copy number per cell,
this ratio was then normalized to the ratio derived from 1C7 cells transfected
with TetR:EYFP that were grown in the presence of doxycycline for the course
of the assay (arbitrary HAC copy number per cell  1).
Chromatin immunoprecipitation (ChIP) to analyze HAC chromatin was
performed essentially as described in Nakano et al. (2008). Monoclonal anti-
bodies used in ChIP were as described in Kimura et al. (2008).
RESULTS
Isolation of a HeLa Hybrid Cell Line Bearing the
AlphoidtetO Synthetic HAC
To study the alphoidtetO HAC in a cell line with favorable
growth and transfection properties, HAC-containing HT1080
cell line AB2.2.18.21 (Nakano et al., 2008) was fused to neo-
mycin-resistant HeLa cells. Clone 1C7, with 1 HAC per
nucleus in 85% of cells (Figure 1A and I) was selected for
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further characterization. 1C7 cells had a morphology typical
of HeLa cells, and a doubling time of 18–20 h.
The synthetic kinetochore of the alphoidtetO HAC assem-
bled a normal complement of kinetochore proteins in 1C7
cells, as shown for CENP-C in Figure 1C. ChIP with specific
antibodies revealed that the HAC alphoidtetO sequences
bound similar levels of CENP-A and H3K4me2 in
AB2.2.18.21 and 1C7 cells, while having appreciable levels of
H3K4me3 only on the active bsr marker gene (Figure 1,
D–H). The alphoidtetO HAC was mitotically stable in 1C7
cells, with a loss rate of 0.0012 per division after growth
without selection for 40 generations (Figure 1I).
The synthetic kinetochore retained its conditional activity
in 1C7 cells. Expressed TetR:EYFP showed a diffuse nuclear
localization plus one bright spot that colocalized with
CENP-A and -C (Supplemental Figure S1A). TetR:EYFP
binding did not affect the localization of CENP-A, -B and -C
recognized by anti-centromere antibodies (ACA; Earnshaw
and Rothfield, 1985) at the synthetic kinetochore. In contrast,
targeting the transcriptional repressor tTS:EYFP to the HAC
kinetochore reduced the ACA signal to 50% (Figure 1J,
Supplemental Figure S1B). We therefore decided to explore
in more detail the events that occur during kinetochore
disruption mediated by the tTS.
Inactivation of the Synthetic Kinetochore by KAP1
The transcriptional silencing function of the tTS is mediated
by a protein domain called the Kruppel-associated box
(KRAB). One principal downstream effector of this class of
transcriptional repressors is the scaffolding protein KAP1
(Kruppel-associated protein 1, also known as TIF1 and
Trim28 (Friedman et al., 1996; Le Douarin et al., 1996; Shojaei
et al., 2004). KAP1 is proposed to recruit chromatin-remod-
elling factors to loci targeted by KRAB-family repressors
(Schultz et al., 2001). To determine whether KAP1 could be
responsible for HAC kinetochore inactivation downstream
of tTS binding, TetR:EYFP was fused to a KAP1 construct
lacking the first 20 residues (KAP120 ; Figure 2A), which
has been reported to function identically to the full-length
protein in in vivo gene silencing assays (Sripathy et al., 2006).
In 1C7 cells transfected with constructs encoding TetR:
EYFP:KAP120, we observed complete loss of CENP-A and
-C from 14% of centromeres at 96 h after transfection (Figure
2, A and C). About half of centromeres with bound TetR:
EYFP:KAP120 lacked detectable CENP-C or CENP-H but
still had CENP-A (Figure 2, A and D). Just over a third of
centromeres with bound TetR:EYFP:KAP120 appeared
structurally normal in these experiments (Figure 2A). This
Figure 1. Isolation and characterization of a
Hela-HT1080 hybrid cell line carrying a stable
alphoidtetO HAC. (A) FISH with a BAC probe
(green in A) on mitotic chromosomes from
the 1C7 cell line with 1 alphoidtetO HAC per
nucleus (arrow in A). (B) FISH on anaphase
1C7 cell. The HAC (green, arrows in B) seg-
regates with the endogenous chromosomes.
Blue, DAPI staining for DNA. (C) Immuno-
FISH with a BAC probe (C, green in the
merged image in C) and antibody against
CENP-C (C’, red in the merged image in C)
on an interphase 1C7 cell. CENP-C colocalizes
with the BAC-probe on the HAC (arrows).
Scale bar, 5 m. (D–H) ChIP with control IgG
antibody (D) and antibodies specific for
CENP-A (E), trimethylated Lysine 9 on his-
tone H3 (F), dimethylated Lysine 4 on histone
H3 (G) and trimethylated Lysine 4 on histone
H3 (H). Real-time PCR on the purified DNA
was performed with primers specific for se-
quences in the actively transcribed Bsr (blas-
ticidin resistance) gene on the BAC vector and
the alphoidtetO array (tetO) forming the HAC
centromere. As controls, primers specific for
the DNA coding for rRNA (5S rDNA), endog-
enous chromosome 21 centromeric alphoid
DNA (chr.21) and endogenous satellite 2
DNA (Sat 2), which is located in the pericen-
tromeric heterochromatin of chromosomes 1
and 16, were used. Error bars, SEM of three
independent ChIP experiments. (I) Analysis
of HAC mitotic stability in 1C7 cells grown
for 40 generations in the absence of blasticidin
selection. The number of HACs per inter-
phase nucleus was determined by FISH with
a BAC probe. (J) Quantification of the amount
of ACA human autoantibody (Earnshaw and
Rothfield, 1985) staining associated with the
alphoidtetO HAC in 1C7 cells fixed 48 h after
transfection with TetR:EYFP and tTS:EYFP.
Values are normalized to the average ACA
staining of endogenous centromeres (100%).
Error bars, SD.
S. Cardinale et al.
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variability could reflect cell cycle differences or differences in
the levels of the expressed proteins.
To test the hypothesis that kinetochore inactivation by
KAP1 requires loss of CENP-A from the kinetochore chro-
matin, we used quantitative fluorescence analysis to deter-
mine the relationship between KAP1-induced loss of
CENP-A and the loss of CENP-C/CENP-H from the al-
phoidtetO kinetochore. Most HACs had a relatively narrow
range of CENP-A antibody binding (intensity values rang-
ing between 100 and 240 arbitrary units in these experi-
ments; left of the vertical dotted line in Figure 3A), but a
much wider range of associated CENP-C (330–2400 arbi-
trary units). On only 4 of 19 HACs with bound TetR:EYFP
was a higher CENP-A signal accompanied by a greater
CENP-C signal.
Line-profile analysis of CENP-A and CENP-C signals at
the disrupted HAC kinetochores with bound TetR:EYFP:
KAP120 suggested that loss of CENP-C does not require a
prior loss or decrease in CENP-A levels at the kinetochore.
Indeed, in this experiment, the levels of CENP-A found on
HACs with very little or no detectable CENP-C were similar
to the levels found on HACs targeted with control TetR:
EYFP (Figure 3A).
When levels of HAC-associated EYFP signals were com-
pared, the amount of bound TetR:EYFP:KAP120 was sim-
ilar to that of TetR:EYFP, although CENP-C levels were
much reduced with the former (Figure 3B). Thus, the differ-
ential effects of TetR:EYFP and TetR:EYFP:KAP120 on ki-
netochore stability cannot be explained by differences in the
efficiency of binding of the two EYFP fusion proteins to the
synthetic kinetochore.
To confirm that the loss of CENP-C occurs independently
of CENP-A loss, and to obtain a better understanding of the
dynamics of KAP1-mediated kinetochore disruption, we
generated a 1C7 derived cell line (1C7-KAP1) stably express-
ing TetR:EYFP:KAP138. These cells were maintained in the
presence of 1 g/ml doxycycline to prevent binding of
TetR:EYFP:KAP138 to the HAC (Materials and Methods). To
examine the time course of events at the HAC kinetochore
after KAP1 binding, we washed out the doxycycline and
subsequently fixed cells for staining with antibodies directed
against either CENP-A or -C after 24, 48, 72, and 96 h. We
have previously shown that stable expression of TetR:EYFP
in AB2.2.18.21 cells for up to 30 d does not affect HAC
stability in most cells (Nakano et al., 2008).
In 1C7-KAP1 cells however, quantification of the HAC-
associated signals revealed a rapid, time-dependent loss of
CENP-C. After only 48 h, 33% of cells failed to display levels
of HAC-associated CENP-C above the background level of
4200 fluorescent units per unit area in these experiments
(Figure 3D). By 72 h, almost 80% of cells lacked detectable
CENP-C staining at the HAC (Figure 3, E and F), and after
96 h, none of the HACs examined were positive for CENP-C.
In the same cells, levels of HAC-associated CENP-A de-
clined much more slowly, with more than 75% of cells
retaining weak but detectable staining after 96 h (Figure 3, C,
G, and H). Consistently, the average fold decrease in me-
dian fluorescent intensity for CENP-C was almost twice
Figure 2. Disruption of the HAC kineto-
chore by KAP120. (A) Schematic of KAP1
and its domains (top). Bottom, the frequency
of the HACs targeted with KAP120 positive
or not for CENP-A and -C or -H is plotted. For
this experiment, 1C7 cells were transfected
with control TetR:EYFP and TetR:EYFP:
KAP120, fixed 96 h after transfection and
costained with the indicated antibodies. Error
bars, SEM. (B–D) Representative images of
the staining of transfected 1C7 cells analyzed
in B. Arrows point to the alphoidtetO HAC.
Colors in merge: blue, EYFP; green, CENP-C;
red, CENP-A. Merged inset, bottom right of
C	 shows only red and green channels. Scale
bar, 5 m.
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that for CENP-A over a 24-h interval within the first 72 h
after doxycycline washout. As a control, average levels of
CENP-A or -C staining at endogenous centromeres did
not change over the course of the experiment (data not
shown).
These experiments demonstrate that KAP1 fused to TetR:
EYFP can effectively disrupt the HAC inner kinetochore as
judged by loss of CENP-C or -H and that this occurs inde-
pendently of effects on CENP-A localization.
Functional Dissection of the Role of KAP1 in Centromere
Inactivation
KAP1 is a scaffold protein that recruits an array of adapter
proteins and chromatin modifiers to loci where it binds.
KAP1 has a modular organization with several well-char-
acterized functional domains (Figure 4A), including a
KRAB-binding N-terminal RBCC (RING finger, B-Box,
coiled coil) region, a HP1-binding region, and a PHD-
finger/Bromodomain. The PHD-finger promotes sumoy-
lation of the Bromodomain, which then provides a specific
binding interface for chromatin modifiers SETDB1 and
NuRD (Ivanov et al., 2007; Zeng et al., 2008), leading to
chromatin-mediated gene silencing (Schultz et al., 2002;
Ivanov et al., 2007).
To identify functional domain(s) of KAP1 capable of kinet-
ochore inactivation, several KAP120 truncation mutants were
fused to TetR:EYFP for HAC targeting. These included (Figure
4A): the RBCC region (KAP1[RBCC], aa 37–425); the HP1-
binding domain (KAP1[HP1D], aa 422–584); a region starting
with residue 20 and including the RBCC and HP1-binding
Figure 3. CENP-C is lost more rapidly than CENP-A from KAP1 targeted HAC kinetochores. (A and B) Measurement of the amounts of
CENP-C and -A (A) or -C and EYFP (B) associated with alphoidtetO HAC in1C7 cells 48h after transient transfection with TetR:EYFP or
TetR:EYFP:KAP120 (n  13–19). (C and D) 1C7-KAP1 cells were fixed and stained for either CENP-A or -C at the indicated time points after
washing out of doxycycline to allow binding of TetR:EYFP:KAP138 to the HAC. Background-subtracted average arbitrary fluorescent units
(AFU) of the HAC associated antibody staining are plotted. The median AFU is indicated for each antibody and time point as solid line in
the graph. The percentage of analyzed HACs showing an AFU value of 4200 (dotted line in the graph) is indicated. Targeting of KAP1
causes levels of CENP-C to diminish more rapidly than levels of CENP-A. (E–H) Maximum intensity projections of cells stained for CENP-C
24 (E) and 72 (F) h after doxycycline washout, with HAC staining corresponding approximately to the median AFU in D. By 72 h, most HACs
lack a detectable CENP-C staining. For CENP-A, time points at 24 (G) and 96 (H) h are shown. Staining corresponds to the median AFU in
C. Even at the 96-h time point, a weak HAC associated CENP-A signal can be detected in the majority of cells. Scale bar, 5 m.
S. Cardinale et al.
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motif (KAP1[20–559], aa 20–559); and the PHD-finger and
Bromodomain (KAP1[PH/BrD], aa 619–835).
Hierarchical disruption of the kinetochore was observed
after the targeting of the various KAP1 subdomains to the
synthetic kinetochore in 1C7 cells. When screened at 96 h
after transfection, the two constructs from the C-terminal
half of KAP1 (TetR:EYFP:KAP1[HP1D] and TetR:EYFP:
KAP1[PH/BrD]) had relatively mild effects. Both failed to
induce the loss of CENP-A from kinetochores, causing the
loss of CENP-C or -H in 6 or 19% of kinetochores, respec-
tively (Figure 4, B and C; Supplemental Figure 2, C and D).
TetR:EYFP:KAP1[RBCC], which contains the N-terminal
half of KAP1, was much more effective at disrupting the
synthetic kinetochore. This protein induced CENP-A loss at
12% of targeted kinetochores, and the loss of either CENP-C
or -H from 34% of the remaining CENP-A-positive kineto-
chores (Figure 4B). All kinetochores that were missing
CENP-A were also missing CENP-C or -H.
Addition of the HP1-binding domain to give TetR:EYFP:
KAP1[20–559] yielded a protein that was even more potent
at disruption of the synthetic kinetochore. In this case
CENP-A was lost from 22% of targeted kinetochores and
39% of the remaining CENP-A–positive kinetochores were
missing CENP-C or -H (Figure 4B).
Given our previous finding that HP1 targeting was suf-
ficient to inactivate the alphoidtetO synthetic kinetochore
(Nakano et al., 2008), we were initially surprised that the
KAP1 HP1-binding domain on its own was not a strong
disrupter of the kinetochore. This was potentially explained
by the observation that TetR:EYFP:KAP1[HP1D] was much
less efficient at recruiting HP1 to the alphoidtetO kineto-
chore than TetR:EYFP:KAP120 (Supplemental Figure S4D).
Figure 4. Disruption of CENP-H and CENP-C kinetochore association. (A) Detailed schematic of the KAP1 subdomains used for targeting.
(B) Frequency of the HACs targeted with KAP1-derived constructs positive or not for CENP-A and -C or CENP-H (n  50–95). 1C7 cells were
transfected with TetR:EYFP or KAP1-derived constructs, fixed 96 h after transfection and costained with the indicated antibodies. (C)
Frequency of HACs targeted with the indicated constructs and positive for CENP-C or -H (n  55–120). (D) Real-time PCR analysis of HAC
retention after transfection with the indicated constructs as described for Figure 3B. Error, SEM. (E and F) HACs targeted with TetR:EYFP:
KAP120 display complete loss of CENP-C (E) and -H (F) staining. Merge: blue, DAPI; green, EYFP; red, CENP-C/H. Scale bar, 5 m.
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KAP1 oligomerization mediated by the RBCC region may
be necessary for optimal KAP1-HP1 interactions. Indeed,
it has been reported that the KAP1 HP1-binding region
requires oligomerization for optimal transcriptional si-
lencing activity and localization at pericentromeric het-
erochromatin (Matsuda et al., 2001).
To better understand the effect of KAP1 constructs on
CENP-C/H kinetochore association, 1C7 cells were trans-
fected and fixed 48 h later for immunostaining. All fusion
proteins tested caused CENP-H loss from 37 to 70% of
kinetochores (Figure 4, C and F; Supplemental Figure S3,
B–D). The same fusion constructs were more variable in
their effects on CENP-C localization at kinetochores. Chime-
ras containing the N-terminal half of KAP1 were most
efficient at disrupting CENP-C binding to the synthetic
kinetochore: only 39% of TetR:EYFP:KAP1[RBCC]-positive
kinetochores and 29% of TetR:EYFP:KAP1[20–559]-positive
kinetochores retained detectible CENP-C (Figure 4, C and E;
Supplemental Figure S2, A and B). In contrast the C-terminal
PHD/Bromodomain and HP1-binding domains (TetR:
EYFP:KAP1[PH/BrD] and TetR:EYFP:KAP1[HP1D]) had lit-
tle effect on CENP-C localization, with 88 and 79% of tar-
geted HACs retaining CENP-C (Figure 4C, Supplemental
Figure S4, B–D). We could observe an apparent tendency of
a given domain to preferentially displace one of the two
assessed centromere proteins over the other, with TetR:
EYFP:KAP1[20–559] showing a higher frequency of loss of
CENP-C relative to CENP-H, and the two C-terminal do-
mains more efficiently displacing CENP-H relative to
CENP-C (Figure 4C), however, this difference was not sta-
tistically significant.
Measurements of the effect of KAP1 domains on HAC
stability in vivo were consistent with the above results on
CENP-C and -H localization. When the various subdomains
were expressed in cells and the levels of HAC DNA deter-
mined by quantitative PCR 12 d later, TetR:EYFP:KAP120,
TetR:EYFP:KAP1[RBCC] and TetR:EYFP:KAP1[20–559]
caused significant loss of the HAC, whereas TetR:EYFP:
KAP1[PH/BrD] was much less effective (Figure 4D). In this
assay, tetR:EYFP:KAP1[HP1D] yielded an intermediate level
of HAC destabilization. Thus, the loss of kinetochore pro-
teins detected in immunofluorescence experiments corre-
sponds to inactivation of the HAC kinetochore.
These results suggest that there is a hierarchy of kineto-
chore disruption by KAP1, with CENP-C and -H being lost
more readily, whereas CENP-A is the more resistant of these
three proteins.
KAP1 Also Disrupts the Outer Kinetochore
To determine whether disruption of the inner kinetochore
by KAP1 also affects other kinetochore regions, we deter-
mined the effect of TetR:EYFP:KAP120 targeting on HEC1/
Ndc80 in the outer kinetochore. At 96 h after transfection,
inner CENP proteins and HEC1/Ndc80 were readily de-
tected on HACs targeted with TetR:EYFP, appearing as two
spots colocalizing with the paired EYFP-dots of the HAC,
which was aligned with the other congressed mitotic chro-
mosomes (Figure 5, A and C). The paired EYFP-dots indicate
that the targeted HAC had replicated, and the distance
between CENP-A spots (1.12 m) suggests that the sister
kinetochores had attached to the mitotic spindle and were
under tension.
TetR:EYFP:KAP120 targeting to the HAC resulted in a
markedly different outcome. In a significant fraction of mi-
totic HACs observed (41%) both inner and outer kineto-
chore proteins were absent (Figure 5E), and the HAC ap-
peared as unresolved EYFP spots lying at the edge of the
congressed chromosomes (see below, Figure 5D). Rarely, on
HACs targeted with TetR:EYFP:KAP120, a HEC1/Ndc80
signal was found only on 1 EYFP-positive HAC sister kinet-
ochore (Figure 5B). To investigate this intriguing observa-
tion in more detail, we quantified fluorescence staining of
CENP-C at mitotic HAC sister kinetochores in the stable
1C7-KAP1 cell line 48 h after washing out of doxycycline.
Strikingly, in a large proportion of cells, the two targeted
HAC sister kinetochores displayed markedly unequal levels
of CENP-C staining (Supplemental Figure S5, A and B). This
trend toward biased kinetochore protein levels was also
observed in cells stained for the outer kinetochore compo-
nents hMis12 and KNL1 (data not shown). Importantly,
unequal levels of CENP-C did not correlate with the amount
of the KAP1 fusion construct bound, as this showed largely
comparable levels on both HAC sister chromatids (Supple-
mental Figure S5B).
Targeting of TetR:EYFP:KAP120 to the synthetic kineto-
chore caused a reduction in the spacing between sister ki-
netochores to 0.93 m in HACs where the two sister chro-
matids were clearly resolved. More commonly (60%),
HACs targeted with TetR:EYFP:KAP120 showed two un-
resolved EYFP dots (Figure 5, B and D), suggesting that they
were experiencing reduced tension across the centromere. In
cases with two unresolved EYFP dots where two CENP-A
spots could be observed, the later were closer together than
normally seen for unattached kinetochores (0.48 m), sug-
gesting that not only were they not under tension, but that
their centromeric heterochromatin was abnormally com-
pacted. These observations could reflect a proposed role of
KAP1 in promoting chromosome condensation (Ziv et al.,
2006).
HACs with disrupted kinetochores (as judged by the ab-
sence of detectible HEC1/Ndc80) were typically found at
the edge of the cluster of congressed chromosomes during
mitosis (Figure 5D). Overall, the number of TetR:EYFP:
KAP120-targeted HACs with a normal metaphase align-
ment was reduced from 100% of HACs with bound TetR:
EYFP to 50% (Figure 5G).
We also assessed HAC alignment defects in the stable
1C7-KAP cell line at 48 and 72 h after removal of doxycy-
cline. Consistent with the observation that HACs in most
interphase nuclei retained readily detectable levels of
CENP-A and -C at the 48-h time point (see Figure 3, C and
D), only 6% (34/36) of HACs failed to show a loss of correct
metaphase alignment in late prometaphase and metaphase
cells (Supplemental Figure S6, A and C). However, by 72 h,
48% (22/42) of HACs were misaligned, and the sister chro-
matids of these unaligned HACs were generally not re-
solved (Supplemental Figure S6, B and C). This is despite
that fact that CENP-A was still detectable in 97% of inter-
phase cells analyzed (Figure 3C).
Combined, these analyses confirmed the hierarchical dis-
ruption of the kinetochore by KAP1, suggesting that KAP1-
induced perturbation of the inner-kinetochore affects the
structure of the outer kinetochore.
DISCUSSION
We previously described the isolation in HT1080 human
fibrosacroma cells of a HAC whose kinetochore is based on
a synthetic DNA sequence containing tetracycline operators
(Nakano et al., 2008). After transfer of this chromosome into
the 1C7 cell hybrid, which retains the growth and transfec-
tion properties of HeLa cells, the HAC retained the chroma-
tin composition previously described in the HT1080 back-
ground with one exception. The synthetic centromere
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appeared to contain less of the heterochromatin-associated
modification H3K9me3 associated with alphoidtetO se-
quences in the more rapidly growing 1C7 hybrid cells. Im-
portantly, the alphoidtetO HAC was extremely stable in 1C7
cells, with a loss rate per division of 0.0012. This is within the
range of mitotic stabilities reported for normal chromo-
somes in cultured cells (Burns et al., 1999). Thus, this HAC is
a relevant model for the study of the epigenetic regulation of
centromere function.
The alphoidtetO HAC is the first experimental system in
which the targeting of a transcriptional repressor into the
kinetochore has been shown to result in kinetochore inacti-
vation (Nakano et al., 2008). This is consistent with studies of
the role of transcription and RNAi in centromere activity in
S. pombe (Volpe et al., 2002, 2003; Chen et al., 2008); however,
the role for transcription in metazoan kinetochore activity
has been little studied (Saffery et al., 2003; Fukagawa et al.,
2004; Wong et al., 2007; Chueh et al., 2009). Our previous
studies found that alphoidtetO kinetochore inactivation by
the tTS correlated with the recruitment of heterochromatin
protein HP1 and that direct recruitment of HP1 as a
TetR:EYFP fusion protein could also inactivate the kineto-
chore (Nakano et al., 2008). This suggested that repressive
chromatin in general might be incompatible with kineto-
chore stability, possibly because of a requirement for tran-
scription within the centromere DNA array.
To understand how heterochromatin inactivates the kinet-
ochore, we examined kinetochore disassembly by the mul-
tidomain scaffolding protein KAP1, a downstream effector of
the tTS. As expected, KAP1 targeting inactivates the syn-
thetic alphoidtetO centromere. However, we could not iden-
tify any single KAP1 domain with a dominant effect on the
integrity of the synthetic kinetochore. Rather, combinatorial
effects appeared to lead to a hierarchical disruption of the
kinetochore. CENP-A is the most robust kinetochore com-
ponent, because KAP1 induces the loss of CENP-C more
rapidly than CENP-A. Furthermore, certain KAP1 domains
showed a mild, though not statistically significant, tendency
to induce the loss of CENP-H more efficiently than CENP-C.
Ultimately the kinetochore was inactivated, as shown by
the loss of the microtubule-binding component Hec1/
Ndc80. These observations suggest that this approach
Figure 5. KAP120 mediates outer kineto-
chore disruption. (A–D) Imaging of the al-
phoidtetO HAC in cells transiently expressing
TetR:EYFP (A and C) or TetR:EYFP:KAP120
(B and D) for 96 h. Fixed cells were costained
with an anti-CENP-A (C and D) or anti-
CENP-C antibody (A and B) and an anti-
Ndc80/HEC antibody (A–D). Colors in
merge: blue, EYFP; green, CENP-A/C; red,
Ndc80/HEC1. Arrows indicate targeted
HACs. Scale bar, 5 m. (E) Frequency of tar-
geted EYFP-positive resolved HAC sisters (as
in A and C). (F) Distance between CENP-A
spots (when distinct) on resolved (as in B) or
unresolved (as in D) HAC sisters. (G) Fre-
quency of targeted HACs aligned across chro-
mosomes congressed on the metaphase plate
(as in C). Error bars, (E–G) SEM.
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may in the future permit a controlled dissection of the
kinetochore in vivo.
Our finding that some mitotic HAC sister kinetochores
targeted by KAP1 display unequal levels of CENP-C is
intriguing. After targeting different constructs, we occasion-
ally observed paired EYFP spots in interphase cells, presum-
ably reflecting tetR fusion constructs binding to replicated
HAC sister chromatids. In some of these cases, we detected
a single spot for any kinetochore component that was asso-
ciated with only one of the two EYFP spots (J.H.B., S.C., and
W.C.E., unpublished data). A comparable observation was
previously reported based on immuno-FISH experiments
showing duplex -satellite signals associated with only a
single ACA spot (Haaf and Ward, 1994).
At present, it is unknown how pre-kinetochore compo-
nents assembled in G1 are distributed onto sister centro-
meres during or after S phase. Our results together with
those of Haaf and Ward (1994) raise the question whether at
least some components of the prekinetochore are seeded on
the newly synthesized centromere DNA after replication
rather than concomitantly. Chromatin modifications intro-
duced by KAP1 might prevent efficient reassembly of these
components onto the new daughter centromere. Although
more detailed analysis of this idea is beyond the scope of the
present manuscript, our HAC system should allow us to
address this question in future experiments, possibly pro-
viding new insights into the replication of the interphase
prekinetochore structure.
There have been numerous studies of kinetochore assem-
bly pathways, but to our knowledge, this is the first study of
single kinetochore inactivation in vivo. We have considered
three models to explain the hierarchical disruption of the
kinetochore induced by targeting of tet-R fusion proteins.
All three models are subject to the caveat that they do not
distinguish between KAP1-mediated disassembly of intact
kinetochores and interference with kinetochore assembly.
In model 1 (Figure 6B), the kinetochore is built on a
chromatin foundation of CENP-A nucleosomes (Palmer and
Margolis, 1985; Palmer et al., 1991; Yoda et al., 2000; Black et
al., 2007; Dalal et al., 2007; reviewed in Carroll and Straight,
2006; Cheeseman and Desai, 2008; Vagnarelli et al., 2008). In
this model, eviction of CENP-A or prevention of its targeting
caused by chromatin modifiers would disrupt the founda-
tion for the kinetochore as a primary effect, and the structure
would subsequently fall apart. This model is not consistent
with our observations. We saw many kinetochores targeted
by KAP1 that lacked detectable CENP-C, but had wild-type
levels of CENP-A. In our previous study, binding of the tTS
transcriptional repressor resulted in recruitment of high lev-
els of H3K9me3 and the reduction of CENP-A chromatin
Figure 6. Models for the disruption of the
alphoidtetO HAC kinetochore mediated by
KAP1 targeting. (A) The alphoidtetO kineto-
chore, with H3 and CENP-A containing nu-
cleosomes (blue and orange, respectively).
CENP-C is associated with H3-containing nu-
cleosomes (Hori et al., 2008). A microtubule
(green) is bound by the KMN complex
(Cheeseman et al., 2006) anchored through the
CCAN (constitutive centromere-associated
network) complex (Cheeseman and Desai,
2008). (B) Model 1, chromatin modifiers evict
CENP-A and causing the kinetochore to fall
apart. (C) Model 2, chromatin modifiers mod-
ify nonchromatin components, causing the ki-
netochore to fall apart. (D) Model 3, chromatin
modifiers alter H3-containing nucleosomes, re-
sulting in dissociation of CENP-C and dissolu-
tion of the kinetochore.
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levels at the alphoidtetO array (Nakano et al., 2008). Our
present data reveal that the loss of CENP-A may follow,
rather than precede, the loss of CENP-C.
Model 2 (Figure 6C) suggests that chromatin modifiers
recruited to the kinetochore by KAP1 may covalently mod-
ify inner or outer kinetochore components other than his-
tones, leading to kinetochore destabilization. One variant of
this model could involve HP1 recruited by the action of
chromatin modifiers disrupting Mis12 complex assembly or
function. HP1 can associate with the Mis12 complex in vivo
and is required for its association with the kinetochore
(Obuse et al., 2004a). Alternatively, the chromatin modifiers
could act on CENP-A chromatin, weakening its links with
associated subunits such as CENP-C and -H, but not causing
dissociation of CENP-A.
A third model (Figure 6D) postulates that the kinetochore
contains both CENP-A and H3-containing nucleosomes.
CENP-C can bind DNA in vitro, and this does not require its
association with CENP-A (Yang et al., 1996), and in Drosoph-
ila, CENP-C is required for efficient CENP-A localization to
kinetochores (Goshima et al., 2007; Erhardt et al., 2008). Fur-
thermore, a recent study has shown nucleosomes containing
CENP-A and H3 to be locally interspersed in the kinetochore
and CENP-C to be associated with H3-containing nucleo-
somes (Hori et al., 2008). This is consistent with an earlier
study in which extensive digestion of chromatin with mi-
crococcal nuclease resulted in a decline in the amount of
CENP-B and -C recovered in CENP-A immunoprecipitates
(Obuse et al., 2004b). According to model 3, chromatin mod-
ifiers recruited by KAP1 would preferentially affect H3 nu-
cleosomes, causing loss of CENP-C without affecting the
properties of CENP-A nucleosomes.
According to either of the latter two models, chromatin
modifiers could cause the loss of kinetochore components
without necessarily requiring the initial loss of CENP-A.
Thus both models are consistent with our observations, and
further experiments are required to determine the mecha-
nism of kinetochore inactivation.
These studies represent a first description of a novel ap-
proach to the study of kinetochore function, and clearly
there is much more to be done before we will fully under-
stand the epigenetic requirements for kinetochore function.
Nonetheless, the present work raises some interesting ques-
tions. How do chromatin modifiers appear to disrupt the
kinetochore from the outside in, rather than from the
CENP-A nucleosome outward? Is it possible that the mod-
ification of kinetochore components by chromatin modifiers
could possibly have a role in observed cell cycle variations in
kinetochore composition and structure? These questions can
be addressed in future studies with the synthetic kineto-
chore.
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